| Name | 5-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-7-hydroxy-2-(4-hydroxyphenyl)chromen-4-one | 
|---|---|
| Synonyms | Camellianin B | 
| Description | Camellianin B, a flavonoid compound, is a Camellianin A metabolite. Camellianin B has antioxidant and angiotensin converting enzyme (ACE) inhibitory activities[1][2]. | 
|---|---|
| Related Catalog | |
| In Vitro | At 500 μg/mL, the ACE inhibitory activities of Camellianin B is 40.68%. Camellianin B has DPPH radical scavenging activity with IC50 value of 1.8 mg/mL[2]. | 
| In Vivo | Camellianin B has a wide tissue distribution with brain penetration[1]. | 
| References | 
| Density | 1.69g/cm3 | 
|---|---|
| Boiling Point | 937.4ºC at 760mmHg | 
| Molecular Formula | C27H30O14 | 
| Molecular Weight | 578.51900 | 
| Flash Point | 312.4ºC | 
| Exact Mass | 578.16400 | 
| PSA | 228.97000 | 
| Vapour Pressure | 0mmHg at 25°C | 
| Index of Refraction | 1.726 |